{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:28:20Z","timestamp":1787538500131,"version":"build-2736575974"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,11,15]]},"DOI":"10.18632\/aging.203687","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T17:49:25Z","timestamp":1636480165000},"page":"24379-24401","source":"Crossref","is-referenced-by-count":19,"title":["Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy"],"prefix":"10.18632","volume":"13","author":[{"given":"Jinzhi","family":"Meng","sequence":"first","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Huang","sequence":"additional","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpu","family":"Huang","sequence":"additional","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpei","family":"Wen","sequence":"additional","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[{"name":"Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma.","volume":"38","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma.","volume":"1","author":"Hauschild","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2217\/fon.14.300","article-title":"Radiotherapy for cutaneous melanoma: current and future applications.","volume":"1","author":"Foote","year":"2015","journal-title":"Future Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.","volume":"10","author":"Allison","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.","volume":"38","author":"Zarour","year":"2014","journal-title":"Lancet"},{"key":"6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.","volume":"1","author":"Chow","year":"2016","journal-title":"Lancet Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.","volume":"36","author":"Patnaik","year":"2013","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: Effectors of Pyroptosis.","volume":"2","author":"Miao","year":"2017","journal-title":"Trends Cell Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3390\/ijms21041456","article-title":"Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer.","volume":"2","author":"Li","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/cr.2016.100","article-title":"Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis.","volume":"2","author":"Han","year":"2016","journal-title":"Cell Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12287","article-title":"Pyroptotic cell death defends against intracellular pathogens.","volume":"26","author":"Miao","year":"2015","journal-title":"Immunol Rev"},{"key":"12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.tranon.2019.04.010","article-title":"Activation of Pyroptotic Cell Death Pathways in Cancer: An Alternative Therapeutic Approach.","volume":"1","author":"Li","year":"2019","journal-title":"Transl Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/cancers11091313","article-title":"The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer.","volume":"1","author":"Wang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"14","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/pr.112.006171","article-title":"The therapeutic potential of modifying inflammasomes and NOD-like receptors.","volume":"6","author":"Di Virgilio","year":"2013","journal-title":"Pharmacol Rev"},{"key":"15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-148X.2012.01008.x","article-title":"Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma.","volume":"2","author":"S\u00f6derkvist","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.taap.2013.03.027","article-title":"Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome.","volume":"27","author":"Yusuf","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"17","doi-asserted-by":"publisher","first-page":"105713","DOI":"10.1016\/j.intimp.2019.105713","article-title":"GSDMD is required for effector CD8T cell responses to lung cancer cells.","volume":"7","author":"Song","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity.","volume":"57","author":"Lieberman","year":"2020","journal-title":"Nature"},{"key":"19","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/bjs.10871","article-title":"Gene expression profiles for a prognostic immunoscore in gastric cancer.","volume":"10","author":"Liao","year":"2018","journal-title":"Br J Surg"},{"key":"20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies.","volume":"2","author":"Lewis","year":"2013","journal-title":"Cancer Cell"},{"key":"21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy.","volume":"4","author":"Pollard","year":"2014","journal-title":"Immunity"},{"key":"22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.","volume":"2","author":"Psyrri","year":"2016","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade.","volume":"12","author":"Seiwert","year":"2017","journal-title":"J Clin Invest"},{"key":"24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.","volume":"1","author":"Manley","year":"2016","journal-title":"Genome Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point.","volume":"54","author":"Mellman","year":"2017","journal-title":"Nature"},{"key":"26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.","volume":"16","author":"Kong","year":"2016","journal-title":"Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.","volume":"34","author":"Moreira","year":"2015","journal-title":"Science"},{"key":"28","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.","volume":"35","author":"Murugaesu","year":"2016","journal-title":"Science"},{"key":"29","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.","volume":"36","author":"Joe","year":"2018","journal-title":"Science"},{"key":"30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer.","volume":"2","author":"Koeffler","year":"2018","journal-title":"Genome Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging inflammasome signals in tumorigenesis and potential targeting.","volume":"1","author":"Kanneganti","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","article-title":"The role of pyroptosis in cancer: pro-cancer or pro-\u201chost\u201d?","volume":"1","author":"Hu","year":"2019","journal-title":"Cell Death Dis"},{"key":"33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.coi.2013.02.009","article-title":"Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.","volume":"2","author":"Spranger","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"34","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1158\/0008-5472.CAN-14-2458","article-title":"Trafficking of T cells into tumors.","volume":"7","author":"Darcy","year":"2014","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1078-0432.CCR-15-0757","article-title":"Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.","volume":"2","author":"Bianchini","year":"2016","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.celrep.2017.04.045","article-title":"Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.","volume":"1","author":"Laurberg","year":"2017","journal-title":"Cell Rep"},{"key":"37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.","volume":"55","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle.","volume":"3","author":"Mellman","year":"2013","journal-title":"Immunity"},{"key":"39","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment.","volume":"1","author":"Fu","year":"2013","journal-title":"Nat Immunol"},{"key":"40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion.","volume":"1","author":"Kurachi","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019.","volume":"1","author":"Schwartzberg","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"42","first-page":"39","article-title":"Prognostic and predictive markers for the new immunotherapies.","volume":"2","author":"Atkins","year":"2014","journal-title":"Oncology (Williston Park)"},{"key":"43","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy.","volume":"1","author":"Atkins","year":"2016","journal-title":"Lancet Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fonc.2016.00141","article-title":"Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation.","volume":"6","author":"Gaipl","year":"2016","journal-title":"Front Oncol"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1903827","article-title":"Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review.","author":"Colloca","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jsb.2017.08.001","article-title":"AIM2 inflammasome activation and regulation: A structural perspective.","volume":"20","author":"Yin","year":"2017","journal-title":"J Struct Biol"},{"key":"47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation.","volume":"26","author":"Kanneganti","year":"2015","journal-title":"Immunol Rev"},{"key":"48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","article-title":"Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples.","volume":"13","author":"Lynch","year":"2012","journal-title":"Theory Biosci"},{"key":"49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"1","author":"He","year":"2012","journal-title":"OMICS"},{"key":"50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.","volume":"1","author":"Trajanoski","year":"2017","journal-title":"Cell Rep"},{"key":"52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.","volume":"2","author":"Issel-Tarver","year":"2000","journal-title":"Nat Genet"},{"key":"53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes.","volume":"2","author":"Goto","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","article-title":"Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.","volume":"9","author":"Cardoso","year":"2006","journal-title":"J Natl Cancer Inst"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T02:50:36Z","timestamp":1637463036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":54,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021,11,15]]}},"alternative-id":["203687","34753832"],"URL":"https:\/\/doi.org\/10.18632\/aging.203687","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]}}}